Premium
Effects of a mind map‐based life review programme on psychospiritual well‐being in cancer patients undergoing chemotherapy: A randomised controlled trial
Author(s) -
Chen Ying,
Xiao Huimin,
Zheng Jianwei,
Zhang Xiaoling,
Lin Xiaoyan
Publication year - 2020
Publication title -
european journal of cancer care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.849
H-Index - 67
eISSN - 1365-2354
pISSN - 0961-5423
DOI - 10.1111/ecc.13221
Subject(s) - medicine , meaning (existential) , transcendence (philosophy) , chemotherapy , distress , randomized controlled trial , psychological distress , cancer , clinical psychology , psychotherapist , mental health , psychiatry , psychology , theology , philosophy
Objectives To evaluate the effects of a mind map‐based life review programme (MBLRP) on psychological distress, hope, meaning in life and self‐transcendence in cancer patients undergoing chemotherapy. Methods Eighty‐four cancer patients undergoing chemotherapy from a university‐affiliated hospital in Fujian, China. The participants were randomly allocated to a MBLRP group ( n = 40) or usual care group ( n = 44). Data were collected at baseline (T0), on the second day (T1) and four weeks after the programme (T2) using the Distress Thermometer, Meaning in Life Questionnaire, Herth Hope Scale and Self‐transcendence Scale. Results No significant interaction effects for time and group membership were found for psychological distress either at T1 ( t = −1.707, p = .090) or at T2 ( t = −1.123, p = .263). The interaction effects for T1 and group membership were statistically significant for meaning in life ( t = 3.487, p = .001) and hope ( t = 5.313, p < .001), but not statistically significant for self‐transcendence ( t = 0.148, p = .882). The interaction effects for T2 and group membership were statistically significant for meaning in life ( t = 2.592, p = .01), hope ( t = 5.215, p < .001) and self‐transcendence ( t = 2.843, p = .005). Conclusions The MBLRP could improve hope, meaning in life and self‐transcendence in cancer patients undergoing chemotherapy.